You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
AUGMENTIN ES is indicated in the short term treatment for acute otitis media when susceptible bacterial pathogens (S. pneumoniae. H. influenzae, M. catarrhalis) are suspected or confirmed. Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to AUGMENTIN ES. However, when there is reason to believe an infection may involve S. pneumoniae with reduced susceptibility to penicillin (penicillin minimum inhibitory concentration (MIC) less than or equal to 4 microgram/mL) or any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. Once these results are known, therapy should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to AUGMENTIN ES, should not require the addition of another antibiotic due to the amoxycillin content of AUGMENTIN ES.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
AUGMENTIN ES is indicated in the short term treatment for acute otitis media when susceptible bacterial pathogens (S. pneumoniae. H. influenzae, M. catarrhalis) are suspected or confirmed. Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to AUGMENTIN ES. However, when there is reason to believe an infection may involve S. pneumoniae with reduced susceptibility to penicillin (penicillin minimum inhibitory concentration (MIC) less than or equal to 4 microgram/mL) or any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. Once these results are known, therapy should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to AUGMENTIN ES, should not require the addition of another antibiotic due to the amoxycillin content of AUGMENTIN ES.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
AUGMENTIN ES is indicated in the short term treatment for acute otitis media when susceptible bacterial pathogens (S. pneumoniae. H. influenzae, M. catarrhalis) are suspected or confirmed. Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to AUGMENTIN ES. However, when there is reason to believe an infection may involve S. pneumoniae with reduced susceptibility to penicillin (penicillin minimum inhibitory concentration (MIC) less than or equal to 4 microgram/mL) or any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. Once these results are known, therapy should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to AUGMENTIN ES, should not require the addition of another antibiotic due to the amoxycillin content of AUGMENTIN ES.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
AUGMENTIN ES is indicated in the short term treatment for acute otitis media when susceptible bacterial pathogens (S. pneumoniae. H. influenzae, M. catarrhalis) are suspected or confirmed. Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to AUGMENTIN ES. However, when there is reason to believe an infection may involve S. pneumoniae with reduced susceptibility to penicillin (penicillin minimum inhibitory concentration (MIC) less than or equal to 4 microgram/mL) or any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. Once these results are known, therapy should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to AUGMENTIN ES, should not require the addition of another antibiotic due to the amoxycillin content of AUGMENTIN ES.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
